R&D News | pharmaphorum

News

Earlybird principal Dr Christoph Massner

VC Earlybird Health raises €173m for healthtech companies

Venture capital group Earlybird has launched its second health fund with €173 million ($185 million) at its disposal to fund companies in the health technology area, more

News

Roche, PathAI team up on AI companion diagnostics

Roche has turned to artificial intelligence specialist PathAI to accelerate development of digital pathology technologies that can be used to match patients with drug treatments and s

News

Biomarkers ‘may predict dementia 15 years before diagnosis’

Researchers in the UK and China have used proteomics data from the UK Biobank to identify protein biomarkers in the blood that could give warning of dementia years before

News

Gilead to buy liver disease specialist CymaBay for $4.3bn

Gilead Sciences has beefed up its pipeline with an agreement to buy CymaBay Therapeutics and its seladelpar drug for rare liver disease primary biliary cholangitis (PBC),

News

FDA fast-tracks GSK’s chronic hep B therapy bepirovirsen

GSK’s antisense-based drug for chronic hepatitis B (CHB), bepirovirsen, will get a rapid six-month review from the FDA when it is filed for approval, said the drugmaker th

News

Apple devices enrich patent data in arthritis trial

It can be challenging to follow the course of rheumatoid arthritis accurately in clinical assessments and trials due to “subtle and unpredictable” changes in symptoms – bu

VC Earlybird Health raises €173m for healthtech companies

Roche, PathAI team up on AI companion diagnostics

Biomarkers ‘may predict dementia 15 years before diagnosis’

Gilead to buy liver disease specialist CymaBay for $4.3bn

FDA fast-tracks GSK’s chronic hep B therapy bepirovirsen

Apple devices enrich patent data in arthritis trial

NHS study will pick apart mental illness with data science

How to meet your physicians where they are online

News

Editor's Picks